Bella Pharmaceuticals Recalls BevaDex Syringes Due to Sterility Concerns
Bella Pharmaceuticals is recalling 200 prefilled BevaDex syringes nationwide because the company cannot guarantee the product's sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in a medical product, which poses a significant risk of serious injury or infection.
Plain-English summary
Bella Pharmaceuticals, Inc. is recalling 200 prefilled syringes of BevaDex (bevacizumab) 0.06mL. The product is a prescription-only medication manufactured by Bella Pharmaceuticals, Inc. in Chicago, Illinois. The specific lot number is 08152017, with an expiration date of 11/15/17.
The recall was initiated due to a lack of assurance of sterility. This means the manufacturer cannot guarantee that the syringes are free from microbial contamination. The affected products were distributed nationwide within the United States.
Consumers and healthcare providers should stop using the affected BevaDex syringes immediately. They should contact their healthcare provider for guidance on alternative treatments and contact Bella Pharmaceuticals at (877) BELLA for further instructions on returning or disposing of the product.
The recalled product
- Product
- BevaDex (bevacizumab) 0.06mL Prefilled 32 g (1.25mg/1mg) Syringes, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659 (877) BELLA.
- Manufacturer
- Bella Pharmaceuticals, Inc.
- Category
- Drug — Ophthalmic
- Affected units
- 200
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 08152017
- Exp. 11/15/17
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by Bella Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Bella Pharmaceuticals, Inc.
See all →- SevereBella Pharmaceuticals Recalls Mannitol 20% Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls B-Complex Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls Fluorescein Sodium Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls L-Glutamine Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereBella Pharmaceuticals Recalls PF-Glutathione Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29